Tyler Technologies Supports Delaware Department of Safety and Homeland Security's Transition to NERIS for Federal Compliance
PLANO, Texas--(BUSINESS WIRE)--Jun 24, 2025--
Tyler Technologies, Inc (NYSE: TYL) announced today an agreement with the Delaware Department of Safety and Homeland Security in collaboration with Tyler's Fire Records and Reporting partner, Emergency Networking, to move to the National Emergency Response Information System (NERIS).
Delaware currently uses multiple public safety solutions from Tyler for its dispatch, law enforcement, and fire needs. Through Tyler's partnership with Emergency Networking, a cloud-native provider of comprehensive fire and EMS records management software, the state will gain access to a single platform for incident reporting, data analysis, and operational oversight. This transition builds on the longstanding relationship between Tyler, Emergency Networking, and Delaware.
'There's no better time to begin this development effort,' said Robert Williams, E-911 administrator for the state of Delaware. 'Our mission is to protect the people and property of Delaware, and this implementation ensures we're doing so in the most efficient, compliant way possible.'
Delaware's transition to NERIS will provide faster data collection, smarter reporting, and deeper analytics while also aligning to new federal mandates and standards. All fire and emergency services departments nationwide must adopt NERIS by January 1, 2026.
'This collaboration is a great opportunity for all parties involved,' said Sean Ramsey, chief executive officer for Emergency Networking. 'Since our system is cloud-native, Delaware will always have access to the latest technology without costly upgrades. We're proud to help the state operate at its highest potential.'
Tyler provides industry-leading public safety solutions to agencies across the U.S. Delaware is a longtime Tyler client currently utilizing Tyler's multi-jurisdictional and integrated public safety solution to provide real-time intelligence to first responders, helping them arrive safer and better prepared to serve their communities. The expansion of the relationship will drive added efficiency to the entire emergency network in Delaware.
'We understand the pressure public safety agencies face adhering to federal reporting standards, and we're confident our collaboration with Emergency Networking will enable Delaware to focus on serving its community in the most efficient way possible,' said Andrew Hittle, president of Tyler's Public Safety Division.
About Tyler Technologies, Inc.
Tyler Technologies (NYSE: TYL) is a leading provider of integrated software and technology services for the public sector. Tyler's end-to-end solutions empower local, state, and federal government entities to operate efficiently and transparently with residents and each other. By connecting data and processes across disparate systems, Tyler's solutions transform how clients turn actionable insights into opportunities and solutions for their communities. Tyler has more than 45,000 successful installations across 13,000 locations, with clients in all 50 states, Canada, the Caribbean, Australia, and other international locations. Tyler has been recognized numerous times for growth and innovation, including on Government Technology's GovTech 100 list. More information about Tyler Technologies, an S&P 500 company headquartered in Plano, Texas, can be found at tylertech.com.
#TYL_Financial
View source version on businesswire.com:https://www.businesswire.com/news/home/20250624462656/en/
CONTACT: Sophie Brenke
Tyler Technologies
972.713.3770
[email protected]
KEYWORD: UNITED STATES NORTH AMERICA TEXAS DELAWARE
INDUSTRY KEYWORD: DATA MANAGEMENT PUBLIC POLICY/GOVERNMENT LAW ENFORCEMENT/EMERGENCY SERVICES STATE/LOCAL TECHNOLOGY OTHER TECHNOLOGY SOFTWARE
SOURCE: Tyler Technologies
Copyright Business Wire 2025.
PUB: 06/24/2025 09:17 AM/DISC: 06/24/2025 09:16 AM
http://www.businesswire.com/news/home/20250624462656/en
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Why KKR Stock Rocketed Almost 5% Higher Today
A top institutional investor was aiming to sell but is now backing off from that plan, according to a media report. This sharply increased confidence in the veteran investment company's stock. 10 stocks we like better than KKR › The equity of sturdy investment company KKR (NYSE: KKR) made for a fine investment all its own on Tuesday. Its stock price leaped by nearly 5% that trading session, thanks to news of a big institutional investor's reversal on a planned sale (which likely would have pushed the stock's price down). KKR's share gain easily beat the slightly over 1% advance of the S&P 500 index. That sizable investor is China Investment Corporation (CIC), the country's sovereign wealth fund. Before market open, Bloomberg, citing unidentified "people familiar with the deal," reported that CIC has canceled a planned sale of several stakes it held in U.S. investment management companies. This list included top names in the sector -- in addition to KKR, positions in Carlyle Group and TPG were to be sold. The sell-off was planned earlier this year as a move to reduce exposure to U.S. businesses. However, at present CIC is no longer interested in such a divestment. The financial news agency didn't cite any reason or reasons for this. U.S. investment bank Evercore was recruited by CIC to broker the sale, Bloomberg and another, earlier article from Reuters stated. Neither China Investment nor Evercore responded to Bloomberg's requests for comment on the matter. Similarly, KKR, Carlyle Group, and TPG haven't yet made official statements regarding it, either. A foreign investor getting cold feet about selling U.S. equities is entirely plausible; earlier this year the world grew increasingly worried that the "punitive" tariffs initially imposed by the Trump administration would damage the U.S. economy. Those concerns are fading quickly, so potential sellers like CIC might be feeling more confident about our country's growth prospects. I wouldn't buy or sell any stock purely on the basis of an institutional investor's move, so I firmly believe folks should hold or ditch KKR entirely on its fundamentals. Given that, it's a wily, veteran company that plies its trade very effectively -- and to me, therefore, is always a consideration for a buy. Before you buy stock in KKR, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and KKR wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $676,023!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $883,692!* Now, it's worth noting Stock Advisor's total average return is 793% — a market-crushing outperformance compared to 173% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 23, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends KKR. The Motley Fool has a disclosure policy. Why KKR Stock Rocketed Almost 5% Higher Today was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
23 minutes ago
- Business Wire
GNTY Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Guaranty Bancshares, Inc. is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Guaranty Bancshares, Inc. (NYSE: GNTY) to Glacier Bancorp, Inc. for 1.0000 share of Glacier stock for each Guaranty share (subject to adjustment under certain circumstances) is fair to Guaranty shareholders. Halper Sadeh encourages Guaranty shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@ or zhalper@ The investigation concerns whether Guaranty and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Guaranty shareholders; (2) determine whether Glacier is underpaying for Guaranty; and (3) disclose all material information necessary for Guaranty shareholders to adequately assess and value the merger consideration. On behalf of Guaranty shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome.
Yahoo
27 minutes ago
- Yahoo
This growth stock just crashed 35%! Time to buy it for my Stocks and Shares ISA?
One growth stock stuck out like a sore thumb when I opened my Stocks and Shares ISA watchlist yesterday (23 June). That was Hims & Hers Health (NYSE: HIMS), which was down almost 35%, registering it's worst-ever day. This is a share I've been watching for a while, but haven't bought yet. Even after yesterday's crash, it's still up 86% over 12 months. Could this crash be an opportune time for me to nip in and open a position? Hims & Hers is a vertically integrated pharmacy and telehealth platform focused on personalised wellness. It offers prescription and over-the-counter treatments for hair loss, mental health, skincare, sexual health, and more. In 2024, the firm's revenue soared 69% year on year to $1.5bn. However, this isn't a jam-tomorrow growth story, because both net income and free cash flow more than quadrupled in Q1 of this year. Subscribers grew 38% to 2.4m. Driving some of this eye-catching growth has been compounded GLP-1 weight-loss drugs, which the firm began selling on its platform in 2024. In May, it announced a partnership with pharmaceutical giant Novo Nordisk to sell its blockbuster Wegovy treatment. Since that announcement, Hims & Hers stock has been rocketing. Until yesterday that is, when Novo terminated the collaboration. In a statement, the firm pulled no punches, accusing Hims of 'illegal mass compounding and deceptive marketing'. It used the words 'knock-off drugs' a number of times in relation to 'personalised' doses of semaglutide that Hims continues to sell. Semaglutide is the active ingredient in Wegovy. More seriously, Novo alleges that potentially unsafe active ingredients are being sourced from foreign suppliers in China, thereby putting patients at risk. Essentially then, there are three allegations here: The continued selling of copycat versions of Wegovy, which Novo says violates regulations. Deceptive marketing of these as 'personalised' treatments. Semaglutide sourced from unapproved Chinese suppliers. In response, Hims' CEO Andrew Dudum wrote on X: 'We refuse to be strong-armed by any pharmaceutical company's anticompetitive demands that infringe on the independent decision making of providers and limit patient choice.' Dudum said Novo's management is 'misleading the public', and that the platform will continue offering access to different weight-loss treatments, including semaglutide. What to make of all this? Well, there could obviously be regulatory compliance risk here. Lawsuits appear inevitable, and there's likely at least some brand damage. Meanwhile, Novo will keep selling Wegovy with two of Hims' rivals, namely Ro and LifeMD. So the firm could lose share in the booming weight-loss space, which isn't ideal. However, there's more to the platform than just Wegovy. It was already growing strongly before GLP-1s, and its opportunity to aggregate demand in some very large health categories appears undimmed to me. It's also expanding into Europe via a recent acquisition. Hims' disruptive direct-to-consumer platform aims to be cheaper and more personalised than the traditional healthcare model. Therefore, I think shareholders should expect further industry resistance, like Uber got from taxi firms. I'd like management to reassure investors about the supply chain accusations. Ideally, this will happen when the firm reports Q2 earnings in August, if not before. But if the stock keeps falling in the coming days, I will open a starter position. The post This growth stock just crashed 35%! Time to buy it for my Stocks and Shares ISA? appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Ben McPoland has positions in Novo Nordisk and Uber Technologies. The Motley Fool UK has recommended Novo Nordisk and Uber Technologies. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
